In serum and lung, the viral loads of TB-Cap, TB-Cap-CD154 and TB-Cap-GM-CSF groups were significantly lower than that of commercial vaccine and PBS groups (p < 0.0001), and the reduction effect was most obvious in serum. Here, CSF2 is linked to tuberculosis.